Moran Kyle bought WVE
December 8, 2025 · Form 4 insider transaction
Moran Kyle bought 60,000 shares of Wave Life Sciences, Inc. at $2.83 per share, a transaction worth $169.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$2.83
Total value
$169.8K
InsiderMoran Kyle
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after149,218
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.